Lead Story
MHRA advances new reform for the treatment of rare diseases
This industry news update explores the MHRA’s upcoming framework that addresses treatments related to rare diseases.
Industry news
EMA ETF offers scientific advice for antimicrobial resistance
This is an industry news update about the EMA’s ETF that offers scientific advice for antimicrobial resistance.
EMA launches #HealthNotHype campaign
This industry news update shares the EMA’s new social media campaign to raise awareness for GLP-1 medicines.
MHRA cuts approval times for UK clinical trials in half
This industry news update announces the MHRA’s decision to reduce clinical trial approvals from 91 days to 41 days.
NICE reviews health technology assessment to better support patients
This industry news update shares NICE’s plans to review how health technologies are evaluated.
Regulatory Rapporteur is back in PDF format
News of an exciting new development for Regulatory Rapporteur starting in October 2025.
MHRA cross-agency team outlines emerging considerations for the manufacture of personalised medicines
This industry news update shares the MHRA’s guidance for the manufacture of personalised medicines.
More news
AI Airlock: Growing the future of artificial intelligence technology in healthcare
NICE increases access to SGLT-2 inhibitors medicines to help treat type 2 diabetes
Survey shapes Regulatory Rapporteur’s future plans
EFPIA publishes guidance document to help support novel methodology submissions
New Director appointed at the FDA’s Center for Drug Evaluation and Research
FDA makes labelling changes to opioid products mandatory
